193 related articles for article (PubMed ID: 3348245)
1. Central nervous system metastases from non-Hodgkin's lymphoma: treatment and prophylaxis.
Recht L; Straus DJ; Cirrincione C; Thaler HT; Posner JB
Am J Med; 1988 Mar; 84(3 Pt 1):425-35. PubMed ID: 3348245
[TBL] [Abstract][Full Text] [Related]
2. Secondary involvement of the central nervous system in malignant non-Hodgkin's lymphoma. A study of 30 cases in a series of 498 patients.
Hoerni-Simon G; Suchaud JP; Eghbali H; Coindre JM; Hoerni B
Oncology; 1987; 44(2):98-101. PubMed ID: 3574856
[TBL] [Abstract][Full Text] [Related]
3. Central nervous system involvement in non-Hodgkin's lymphomas: value of lumbar puncture as initial staging procedure.
Monfardini S; Ficarra G; Giardini R; Santoro A
Tumori; 1981; 67(3):197-202. PubMed ID: 7281238
[TBL] [Abstract][Full Text] [Related]
4. Central nervous system involvement in non-Hodgkin's lymphoma.
Liang RH; Woo EK; Yu YL; Todd D; Chan TK; Ho FC; Tso SC; Shum JS
Eur J Cancer Clin Oncol; 1989 Apr; 25(4):703-10. PubMed ID: 2714346
[TBL] [Abstract][Full Text] [Related]
5. Primary non-Hodgkin's lymphoma of the CNS treated with CHOD/BVAM or BVAM chemotherapy before radiotherapy: long-term survival and prognostic factors.
Bessell EM; Graus F; Lopez-Guillermo A; Lewis SA; Villa S; Verger E; Petit J
Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):501-8. PubMed ID: 15145169
[TBL] [Abstract][Full Text] [Related]
6. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C
Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012
[TBL] [Abstract][Full Text] [Related]
7. Pathology with clinical correlations of primary central nervous system non-Hodgkin's lymphoma. The Massachusetts General Hospital experience 1958-1989.
Miller DC; Hochberg FH; Harris NL; Gruber ML; Louis DN; Cohen H
Cancer; 1994 Aug; 74(4):1383-97. PubMed ID: 8055462
[TBL] [Abstract][Full Text] [Related]
8. Intrathecal chemotherapy alone is inadequate central nervous system prophylaxis in patients with intermediate-grade non-Hodgkin's lymphoma.
Chua SL; Seymour JF; Streater J; Wolf MM; Januszewicz EH; Prince HM
Leuk Lymphoma; 2002 Sep; 43(9):1783-8. PubMed ID: 12685832
[TBL] [Abstract][Full Text] [Related]
9. Non-Hodgkin's lymphoma of the central nervous system after treatment of Hodgkin's disease.
Miller DC; Knee R; Schoenfeld S; Wasserstrom WR; Karp G
Am J Clin Pathol; 1989 Apr; 91(4):481-5. PubMed ID: 2929506
[TBL] [Abstract][Full Text] [Related]
10. Central nervous system relapse of systemic non-Hodgkin's lymphoma: results of treatment based on high-dose methotrexate combination chemotherapy.
Bokstein F; Lossos A; Lossos IS; Siegal T
Leuk Lymphoma; 2002 Mar; 43(3):587-93. PubMed ID: 12002763
[TBL] [Abstract][Full Text] [Related]
11. Predictive factors for central nervous system involvement in non-Hodgkin's lymphoma: significance of very high serum LDH concentrations.
Tomita N; Kodama F; Sakai R; Koharasawa H; Hattori M; Taguchi J; Fujita H; Tanabe J; Fujisawa S; Fukawa H; Harano H; Kanamori H; Miyashita H; Matsuzaki M; Ogawa K; Motomura S; Maruta A; Ishigatsubo Y
Leuk Lymphoma; 2000 Jul; 38(3-4):335-43. PubMed ID: 10830740
[TBL] [Abstract][Full Text] [Related]
12. CNS involvement by non-Hodgkin's lymphoma. Response to a standard therapeutic protocol.
Raz I; Siegal T; Siegal T; Polliack A
Arch Neurol; 1984 Nov; 41(11):1167-71. PubMed ID: 6487100
[TBL] [Abstract][Full Text] [Related]
13. Central nervous system involvement in T-cell lymphoma: A single center experience.
Gurion R; Mehta N; Migliacci JC; Zelenetz A; Moskowitz A; Lunning M; Moskowitz C; Hamlin P; Horwitz S
Acta Oncol; 2016 May; 55(5):561-6. PubMed ID: 27046135
[TBL] [Abstract][Full Text] [Related]
14. CNS involvement in the non-Hodgkin's lymphomas.
Levitt LJ; Dawson DM; Rosenthal DS; Moloney WC
Cancer; 1980 Feb; 45(3):545-52. PubMed ID: 6986199
[TBL] [Abstract][Full Text] [Related]
15. Central nervous system complications by malignant lymphomas: radiation schedule and treatment results.
Aabo K; Walbom-Jørgensen S
Int J Radiat Oncol Biol Phys; 1986 Feb; 12(2):197-202. PubMed ID: 3949570
[TBL] [Abstract][Full Text] [Related]
16. Autografting followed by nonmyeloablative immunosuppressive chemotherapy and allogeneic peripheral-blood hematopoietic stem-cell transplantation as treatment of resistant Hodgkin's disease and non-Hodgkin's lymphoma.
Carella AM; Cavaliere M; Lerma E; Ferrara R; Tedeschi L; Romanelli A; Vinci M; Pinotti G; Lambelet P; Loni C; Verdiani S; De Stefano F; Valbonesi M; Corsetti MT
J Clin Oncol; 2000 Dec; 18(23):3918-24. PubMed ID: 11099321
[TBL] [Abstract][Full Text] [Related]
17. Improved survival rate in children with stage III and IV B cell non-Hodgkin's lymphoma and leukemia using multi-agent chemotherapy: results of a study of 114 children from the French Pediatric Oncology Society.
Patte C; Philip T; Rodary C; Bernard A; Zucker JM; Bernard JL; Robert A; Rialland X; Benz-Lemoine E; Demeocq F
J Clin Oncol; 1986 Aug; 4(8):1219-26. PubMed ID: 3525767
[TBL] [Abstract][Full Text] [Related]
18. Failed central nervous system prophylaxis in children with acute lymphoblastic leukaemia: treatment and outcome.
Pinkerton CR; Chessells JM
Br J Haematol; 1984 Aug; 57(4):553-61. PubMed ID: 6589013
[TBL] [Abstract][Full Text] [Related]
19. The Outcomes of Diffuse Large B-cell Lymphoma Patients with Synchronous and Early Central Nervous System Involvement: A Single-Center Experience.
Al-Mansour M; Saif SA; Alharbi Z; Alhwaity AS; Almasrahi A; Alnejadi W; Hussain S; Aga SS; Khan MA; Almufti R; Absi A
Asian Pac J Cancer Prev; 2023 Feb; 24(2):623-631. PubMed ID: 36853313
[TBL] [Abstract][Full Text] [Related]
20. Primary central nervous system non-Hodgkin's lymphoma: survival advantages with combined initial therapy?
O'Neill BP; O'Fallon JR; Earle JD; Colgan JP; Brown LD; Krigel RL
Int J Radiat Oncol Biol Phys; 1995 Oct; 33(3):663-73. PubMed ID: 7558957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
